Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biodynamics Plc LSE:OBD London Ordinary Share GB00BD5H8572 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -7.25 -8.68% 76.25 56,458 16:35:26
Bid Price Offer Price High Price Low Price Open Price
75.00 77.50 82.00 77.00 82.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.91 -3.39 -3.00 71
Last Trade Time Trade Type Trade Size Trade Price Currency
16:29:43 AT 34 77.00 GBX

Oxford Biodynamics (OBD) Latest News

More Oxford Biodynamics News
Oxford Biodynamics Investors    Oxford Biodynamics Takeover Rumours

Oxford Biodynamics (OBD) Discussions and Chat

Oxford Biodynamics Forums and Chat

Date Time Title Posts
01/10/202006:08Oxford BioDynamics PLC197
11/4/201814:30Oxford Biodynamics INTERVIEW1
21/3/201813:47Oxford Biodynamics PLC Interview and Q&A-

Add a New Thread

Oxford Biodynamics (OBD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-10-30 16:29:4377.003426.18AT
2020-10-30 16:24:4777.001,062817.74O
2020-10-30 16:24:4777.00706543.62AT
2020-10-30 16:24:4777.002,6322,026.64AT
2020-10-30 16:24:4077.004,4003,388.00O
View all Oxford Biodynamics trades in real-time

Oxford Biodynamics (OBD) Top Chat Posts

Oxford Biodynamics Daily Update: Oxford Biodynamics Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker OBD. The last closing price for Oxford Biodynamics was 83.50p.
Oxford Biodynamics Plc has a 4 week average price of 77p and a 12 week average price of 72.50p.
The 1 year high share price is 148p while the 1 year low share price is currently 47p.
There are currently 92,559,771 shares in issue and the average daily traded volume is 81,437 shares. The market capitalisation of Oxford Biodynamics Plc is £70,576,825.39.
rambutan2: Unsure how relevant re dates and quite where OBD work fits in to timeline: htTps://
sjames1: Interesting how the price has been creeping better. Perhaps news of Covid work with Glasgow University imminent?
jaws6: most we know but good Q & A afterwards on Covid, contract in US , and few on this too Https://
astralvision: Webinar next week with OBD, could be interesting.You ain't going to do one unless you've got something good to say!
hamidahamida: Missed out on nyct obd try MWG a COVID19 player still capped below 10m Business has started to boom ..I feel now that media around the world has started talking about covid19 in waste water #MWG wil do a NCYT type of share price surge bcz its dominant position in waste water and sewage testing for viruses with its thousands of installed Microtox test systems around the world soon to be retrofitted with #AI real time alerts for COVID19 and other viruses...GB these studies are done, how do you put in place a permanent real-time alert system? BBC News - Coronavirus: Sewage study could predict second Covid-19 peak
hedgehog 100: OBD is looking very oversold at just 52.5p, and due a recovery like many other biotechs recently. It has a strong cash position: £15.5M. as at 30.9.19, compared to a full year pre-tax loss of just £3.386M. And personalised medicine could have an important role to play in tackling coronavirus, considering how coronavirus's effect, and the effect of its treatment, appears to vary according to a persons's genetics. "Coronavirus symptoms: Susceptibility to COVID-19 could be genetic - experts CORONAVIRUS infections could be targeting people more genetically predisposed towards COVID-19, researchers have claimed. By SEBASTIAN KETTLEY PUBLISHED: 21:28, Fri, Mar 20, 2020 | UPDATED: 23:00, Fri, Mar 20, 2020 ... The researchers told the Polish Press Agency (PAP) certain genetic characteristics or variations can affect how people react to COVID-19 and medication. ..." From OBD's website home page:- "INNOVATION SAVING LIVES We are a biotechnology company with a proprietary epigenetic biomarker discovery platform, EpiSwitch™, based on the latest advances in regulatory genome architecture and its link to clinical outcomes and patient stratification. EpiSwitch™ biomarkers based on chromosomal conformation signatures are a critical cog in personalised medicine. Technology to select the right drug at the right dose at the right time for the right patient. EpiSwitch TM Accelerated development of companion diagnostics for the pharmaceutical industry." HTTP:// From OBD's final results to 30.9.19, released 10.12.19: " ... Corporate and operational highlights ▪ Continued development of EpiSwitch™ biomarkers for use in immuno-oncology (IO), including signing of fifth commercial collaboration. ... "
czeck: Added more here; another large Director buy - 40,000 Ordinary Shares of 1 pence each at a price of 90p per share. (£36,000.00) HTTPS://
cokehookerscars: I got into this at quite literally the worst time. Near 50% down at the moment. They talked a good game and I believed in it. Their activities should be making good progress but just aren't. Is it competition beating them (I don't think so) or other organisations just not very interested in taking up their services. To an outsider (of the biotech world) this companies offerings sound like they would be in significant demand but it just isn't happening. Are there companies I'm not aware of doing the same as OBD but better ? Or is OBD doing a poor job of showing the benefits ? OR are their services just not as useful in the real world as they sound to a layman ??
badger60: OBD is now trading at near its all time lows, and less than 50% of the share price at its ramped up peak in late 2017... OBD is shaping up to be virtually identical to PRM which has been on financial life support for the last 10+ years and has an overvalued mkt cap of 9 Mio quid. PRM has consistently lost 2-3mio every year and never earned an honest penny in revenue since Moses was given the 10 Commandments..
badger60: Oh dear. It looks like the 2 resignations are hitting the share price. I wonder why they are leaving?
Oxford Biodynamics share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Oxford Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201031 05:23:27